EUVIMEDEUVIMED entdecken
Crossref

Development of Dihydrorugosaflavonoid/hydroxypropyl‐β‐cyclodextrin Inclusion Complex: Dissolution Properties, Thermal Stability, Anticancer Activity, and In Vivo Toxicity Studies

Garima Mishra, Akansha Raut, Ashwini V. Misar, Pratibha Srivastava

ChemistrySelect · 2025-09 · 10 (35)

DOI: 10.1002/slct.202500357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 12.09.2025. Verfasst von Garima Mishra und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present investigation aimed to form the inclusion complex of flavonoid Rosa rugosa , i.e., dihydrorugosaflavonoid (DHR), with 2‐hydroxypropyl‐β‐cyclodextrin (HP‐β‐CD) for the first time. The DHR/HP‐β‐CD inclusion complex was formulated by the freeze‐drying method. A phase solubility study was carried out to find the stability constant of the complex. The results show the formation of the DHR/HP‐β‐CD inclusion complex with the stoichiometry ratio of 1:1 (A L type) as an enthalpy‐driven process. The inclusion complex of DHR/HP‐β‐CD was characterized by FT‐IR, 1 H‐NMR, XRD, and SEM techniques. The thermogravimetric analysis DSC and TGA, confirmed the inclusion complex's formation. Phase solubility analysis results showed that the aqueous solubility of DHR was increased up to ∼136‐fold at 12 mM of HP‐β‐CD conc. Compared with DHR, the solubility of DHR/HP‐β‐CD complex was significantly enhanced 32‐fold after 40 min. The anticancer (IC 50 ) activity against MCF7 breast cancer cell lines was obtained at 2.5 µM. The acute toxicity study on Swiss albino mice showed no significant toxicity symptoms till 100 mg/kg after oral administration of pure DHR and DHR/HP‐β‐CD inclusion complex. The present study may enhance the scope of flavonoids of R. rugosa , including DHR, to make it more accessible for oral absorption.

Zitieren

APA

Mishra, G., Raut, A., Misar, A. V., & Srivastava, P. (2025). Development of Dihydrorugosaflavonoid/hydroxypropyl‐β‐cyclodextrin Inclusion Complex: Dissolution Properties, Thermal Stability, Anticancer Activity, and In Vivo Toxicity Studies. ChemistrySelect, 10(35). https://doi.org/10.1002/slct.202500357

Vancouver

Mishra G, Raut A, Misar AV, Srivastava P. Development of Dihydrorugosaflavonoid/hydroxypropyl‐β‐cyclodextrin Inclusion Complex: Dissolution Properties, Thermal Stability, Anticancer Activity, and In Vivo Toxicity Studies. ChemistrySelect. 2025;10(35). doi:10.1002/slct.202500357

BibTeX
@article{Mishra2025,
  author = {Mishra, Garima and Raut, Akansha and Misar, Ashwini V. and Srivastava, Pratibha},
  title = {Development of Dihydrorugosaflavonoid/hydroxypropyl‐β‐cyclodextrin Inclusion Complex: Dissolution Properties, Thermal Stability, Anticancer Activity, and In Vivo Toxicity Studies},
  journal = {ChemistrySelect},
  year = {2025},
  volume = {10},
  number = {35},
  doi = {10.1002/slct.202500357}
}
Kostenlos starten →